Anti-ictogenic effects of the corticotropin-releasing factor-like peptide in the pentylenetetrazole model of seizure in brain slices.

Epilepsy Res

I. P. Pavlov Institute of Physiology, Russian Academy of Science, Nab. Makarova, 6, Saint-Petersburg 199034, Russia. Electronic address:

Published: March 2014

The present study provides evidence for anti-ictogenic activity of the mystixin 7 (MTX) mini-peptide in the pentylenetetrazole model of seizure. MTX was effective in inhibiting/suppressing ictal- and interictal-like activities over a long period of time (during 60-80min). The peptide's anti-ictogenic effects were concentration- and time-dependent. An enzymatic treatment of MTX was accompanied by a decrease of the frequency pattern of epileptiform discharges, but their total blockade did not occurred. These findings indicate that the MTX mini-peptide has pronounced anti-ictogenic properties.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eplepsyres.2014.01.002DOI Listing

Publication Analysis

Top Keywords

anti-ictogenic effects
8
pentylenetetrazole model
8
model seizure
8
mtx mini-peptide
8
anti-ictogenic
4
effects corticotropin-releasing
4
corticotropin-releasing factor-like
4
factor-like peptide
4
peptide pentylenetetrazole
4
seizure brain
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!